Adagene
ADAG
$2.55
Share price
4.51%
Change (1 day)
68.87%
Change (1 year)
Categories
Earnings for Adagene (ADAG)
Earnings in 2020 (TTM): -$28.83 M
According to Adagene's latest financial reports the company's current earnings (TTM) are -$79.52 M. In 2022 the company made an earning of -$79.52 M a decrease over its 2021 earnings that were of -$71.48 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Adagene from 2018 to 2020
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 | -$79.52 M | 11.24% |
| 2021 | -$71.48 M | 68.59% |
2020  | -$42.4 M | 158.01% |
| 2019 | -$16.44 M | 7.64% |
| 2018 | -$15.27 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | -$19.09 M | -76.00% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | -$73.07 M | -8.11% | 🇬🇧 UK |
 Novavax NVAX | -$0.53 B | 564.82% | 🇺🇸 USA |
 Novocure
NVCR | -$0.17 B | 113.41% | Jersey |